Radiofrequency ablation for pain (RFA), also known as thermal neurotomy (nerve thermal disruption), is a specialized procedure within interventional pain medicine. The primary goal of RFA is to interrupt sensory pain pathways transmitting pain signals from degenerate or inflamed musculoskeletal structures to the central nervous system. By delivering targeted electromagnetic energy through specialized insulated needles, clinicians create localized thermal lesions on target sensory nerves, such as the medial branch nerves (sensory nerve supply to spinal joints) or genicular nerves (sensory nerve supply to the knee joint).

This treatment belongs to the discipline of interventional pain management and anesthesiology. RFA is indicated when conservative measures—including physical therapy, anti-inflammatory medications, and exercise therapy—have proven inadequate, and diagnostic nerve blocks have confirmed the precise anatomical source of pain. The thermal lesion leads to Wallerian degeneration (predictable breakdown of the nerve axon distal to the lesion site), preventing signal conduction while leaving surrounding vascular and motor structures intact.

The patient is positioned prone or supine on a radiolucent fluoroscopy table depending on the target anatomy. Standard vital sign monitoring equipment is attached. The skin overlying the intervention site is cleansed with antiseptic solution and draped sterilely. Under live fluoroscopic or ultrasound imaging, local anesthetic (1% or 2% lidocaine) is injected into the skin and subcutaneous tissue. Specialized radiofrequency cannulas (typically 18 to 22 gauge) with uninsulated active tips (5mm to 10mm) are advanced under real-time fluoroscopic guidance until the tip rests precisely along the anatomical course of the target sensory nerve (such as the junction of the transverse process and superior articular process for lumbar medial branches). Precise needle location is verified using multi-planar fluoroscopic views (anteroposterior, lateral, and oblique views). Sensory testing is performed by applying a low-voltage electrical current (50 Hz, 0.2 to 0.5 Volts); reproduction of the patient's typical pain confirms proximity to the target sensory nerve. Motor stimulation testing is subsequently performed at 2 Hz up to 1.5 to 2.0 Volts; absence of motor twitching in the lower or upper extremities confirms that the needle tip is at a safe distance from primary motor spinal nerves. Local anesthetic (e.g., 0.5 mL of 2% lidocaine or 0.5% bupivacaine) is injected through the cannula to numb the area prior to thermal lesioning. The radiofrequency generator is activated, heating the electrode tip to 80°C for 60 to 90 seconds per site. Multi-lesion techniques or dual-needle placements may be used to cover anatomical variations. Upon completion, the cannulas are removed, light pressure is applied to stop minor bleeding, and sterile dressings are placed over insertion sites.

Evidence-based clinical studies demonstrate several distinct advantages of radiofrequency ablation for appropriately selected chronic pain patients:

• Sustained Pain Relief: Provides substantial pain reduction lasting 6 to 24 months, significantly outlasting local corticosteroid or local anesthetic injections (American Society of Regional Anesthesia and Pain Medicine [ASRA] Consensus Guidelines, Cohen et al., 2020).
• Functional Restoration: Improves physical mobility, range of motion, and performance in daily activities, allowing patients to participate more effectively in physical therapy (Spine Intervention Society [SIS] Practice Guidelines, Bogduk et al., 2013).
• Reduction in Medication Reliance: Facilitates significant reduction or discontinuation of long-term prescription opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), and neuropathic medications (American Society of Interventional Pain Physicians [ASIPP] Guidelines, Manchikanti et al., 2020).
• Minimally Invasive Outpatient Profile: Avoids major surgical exposure, general anesthesia risks, prolonged hospital stays, and extensive tissue trauma.
• Repeatability: When nerve regeneration eventually occurs and pain symptoms return, RFA can be safely repeated with comparable efficacy and safety profiles.

Recovery following radiofrequency ablation is structured around distinct physical healing phases:

• Days 1 to 3 (Immediate Post-Procedure): Patients experience local superficial soreness, skin bruising, or transient superficial burning at needle entry points. Activity is limited to light indoor walking. Ice therapy applied for 20 minutes per hour helps control localized tissue inflammation.
• Days 4 to 14 (Intermediate Healing Phase): Localized muscle soreness gradually subsides. Patients may experience temporary paresthesia (altered skin sensation or tingling) over the treated dermatome. Routine non-strenuous daily activities are resumed, but heavy lifting (>10 lbs/4.5 kg) and vigorous exercise remain restricted.
• Weeks 2 to 4 (Onset of Full Relief): The initial inflammatory response resolves completely, and therapeutic pain relief becomes clinically apparent. Patients begin or resume structured physical therapy to restore core stability and joint biomechanics.
• Months 1 to 12+ (Maintenance Phase): Peak therapeutic outcome is established. Patients undergo formal clinical evaluation at 4 to 6 weeks to document pain score changes and functional capacity. Follow-up visits occur periodically to monitor pain stability.

Radiofrequency ablation is indicated for several chronic recalcitrant pain conditions affecting the spine and peripheral axial skeleton:

• Cervical, Thoracic, and Lumbar Facet Joint Arthropathy: Chronic neck, mid-back, or lower back pain resulting from spondylosis (degenerative osteoarthritis of the spine facet joints).
• Sacroiliac Joint Dysfunction: Chronic lower back and buttock pain originating from inflammation or mechanical instability of the sacroiliac joint (the joint connecting the sacrum to the pelvis).
• Knee Osteoarthritis Pain: Chronic knee joint pain in non-surgical candidates or post-arthroplasty persistent pain, targeted via the genicular nerves (sensory branches supplying the knee capsule).
• Hip Joint Osteoarthritis Pain: Chronic deep hip pain targeted via articular sensory branches of the femoral and obturator nerves.
• Occipital Neuralgia: Refractory cervicogenic headaches originating from irritation of the occipital nerves (typically managed with pulsed radiofrequency protocol).
• Thoracic Intercostal Neuralgia: Chronic localized chest wall or rib pain following trauma, herpes zoster, or thoracic surgery.

Pre-procedure workup requires documented diagnostic confirmation via fluoroscopically guided diagnostic nerve blocks yielding at least 50% to 80% temporary pain relief. Patients must undergo full medical reconciliation. Anticoagulant and antiplatelet medications (such as warfarin, clopidogrel, rivaroxaban, or apixaban) must be withheld for specific timeframes prior to the procedure based on American Society of Regional Anesthesia and Pain Medicine (ASRA) anti-coagulation guidelines, under strict coordination with the prescribing cardiologist or primary physician. Patients with cardiac pacemakers or implantable cardioverter-defibrillators (ICDs) require preoperative electrophysiology evaluation to ensure grounding pad placement will not interfere with device function or trigger inappropriate pacing. Solid food must be restricted for 6 hours prior to the procedure; clear liquids are permitted up to 2 hours before arrival if mild intravenous conscious sedation is planned. Patients must arrange for a responsible adult driver to provide transportation home after discharge.

Common and mild side effects include transient localized procedural pain (occurring in 10% to 20% of patients for 3 to 10 days post-procedure), minor localized bruising, and temporary localized hypesthesia (reduced skin sensation) over the treated area. Less common risks include localized neuritis (inflammatory nerve irritation causing transient burning pain or hyperalgesia, seen in 2% to 5% of cases, typically resolving over 2 to 6 weeks with oral conservative management). Rare and serious complications include localized soft tissue or epidural infection (<0.1%), localized hematoma formation (<0.1%), motor nerve injury resulting in localized muscle weakness (<0.1%), inadvertent thermal injury to non-target tissue or major nerve roots (<0.05%), and pneumothorax (during thoracic-level spine procedures, <0.05%). Systemic risks from local anesthetic toxicity or allergic reaction to contrast media are exceptionally rare when standard clinical resuscitation protocols are maintained.

The patient clinical journey for radiofrequency ablation follows a structured, multi-step diagnostic and therapeutic pathway designed to maximize treatment precision and patient safety:

• Diagnostic Evaluation Phase: Initial clinical consultation, physical examination, and review of magnetic resonance imaging (MRI) or computed tomography (CT) scans. The patient undergoes one or two diagnostic medial branch blocks (local anesthetic injections targeting specific sensory nerves) to verify that the target joint is the primary pain generator. A positive response (typically 50% to 80% temporary pain reduction) validates proceeding to ablation.
• Pre-Procedure Preparation: Laboratory screening for bleeding risks, temporary discontinuation of anticoagulant medications under prescribing clinician guidance, and pre-procedure fasting protocols.
• Procedure Day: Performed in an outpatient surgical suite. Local anesthesia is administered, with optional mild intravenous sedation. Utilizing continuous fluoroscopy (real-time X-ray imaging), specialized cannulas are positioned adjacent to target nerves. Sensory and motor electrical stimulation testing confirms accurate needle location prior to heating. Thermal energy is applied for 60 to 90 seconds per target node.
• Immediate Post-Procedure: Observation in a recovery area for 60 to 120 minutes to monitor vital signs and lower extremity motor function. Discharge occurs on the same day with an adult escort.
• Recovery and Follow-up: Initial localized soreness lasts 3 to 14 days, managed with cold therapy and simple analgesics. Substantial pain reduction typically develops between 2 and 4 weeks post-procedure. A formal follow-up evaluation occurs at 4 to 6 weeks to measure functional improvement and initiate active physical rehabilitation.